Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.

Clinical endocrinology - 1 Jan 2012

van Wijk J P H, Dreijerink K M A, Pieterman C R C, Lips C J M, Zelissen P M J, Valk G D

Abstract excerpt

OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome characterized by parathyroid, gastroenteropancreatic, pituitary and adrenal tumours. Cardiovascular disease has been identified as an important cause of death in MEN1 patients. Menin, the product of the MEN1 gene, is a co-activator for peroxisome proliferator-activated receptor-γ and the vitamin D receptor, which are involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to MEN1 gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homeostasis

Share to Insulin Resistance

Share to Mutation

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 21726266
DOI: 10.1111/j.1365-2265.2011.04166.x

Genes

MEN1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.PMID 21726266Read ↗

Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.Semantic proximity Read ↗

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)Semantic proximity Read ↗

Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.Semantic proximity Read ↗

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.Semantic proximity Read ↗

MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.Semantic proximity Read ↗

Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report.Semantic proximity Read ↗

Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study.Semantic proximity Read ↗

An Indian family of multiple endocrine neoplasia type 1 (MEN1): molecular diagnosis, treatment and follow up.Semantic proximity Read ↗

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.Semantic proximity Read ↗

Novel mutation 928G>C of MEN1 gene in a familial multiple endocrine neoplasia type 1 case (MEN1) with co-existence of insulinoma and glucagonoma.Semantic proximity Read ↗

Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindred.Semantic proximity Read ↗

[Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.